日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trend of Outcome Metrics in Recent Out-of-Hospital-Cardiac-Arrest Research: A Narrative Review of Clinical Trials

近期院外心脏骤停研究中结局指标的趋势:临床试验的叙述性综述

Htet, Natalie N; Jafari, Daniel; Walker, Jennifer A; Pourmand, Ali; Shaw, Anna; Dinh, Khai; Tran, Quincy K

Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)

胰岛素受体底物-1 (IRS-1) 和 IRS-2 表达水平与非小细胞肺癌 (NSCLC) 的预后相关

Piper, Andrew J; Clark, Jennifer L; Mercado-Matos, Jose; Matthew-Onabanjo, Asia N; Hsieh, Chung-Cheng; Akalin, Ali; Shaw, Leslie M

Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer

一项北美II期研究中,阿来替尼治疗ALK阳性、克唑替尼耐药的非小细胞肺癌患者的患者报告结局

Ou, Sai-Hong Ignatius; Socinski, Mark A; Gadgeel, Shirish; Gandhi, Leena; West, Howard; Chiappori, Alberto Alejandro; Cohen, Victor; Riely, Gregory J; Smoljanovic, Vlatka; Bordogna, Walter; Wright, Elaine; Debusk, Kendra; Zeaiter, Ali; Shaw, Alice T

Whole-Genome and Whole-Exome Sequencing in Pediatric Oncology: An Assessment of Parent and Young Adult Patient Knowledge, Attitudes, and Expectations

儿童肿瘤学中的全基因组和全外显子组测序:对家长和年轻患者的知识、态度和期望的评估

Oberg, Jennifer A; Ruiz, Jenny; Ali-Shaw, Trisha; Schlechtweg, Kathryn A; Ricci, Angela; Kung, Andrew L; Chung, Wendy K; Appelbaum, Paul S; Glade Bender, Julia L; Levine, Jennifer M

Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK-positive Non-Small Cell Lung Cancer

来自关键性 II 期研究(NP28673 和 NP28761)的阿来替尼治疗 ALK 阳性非小细胞肺癌的系统疗效和安全性汇总数据

Yang, James Chih-Hsin; Ou, Sai-Hong Ignatius; De Petris, Luigi; Gadgeel, Shirish; Gandhi, Leena; Kim, Dong-Wan; Barlesi, Fabrice; Govindan, Ramaswamy; Dingemans, Anne-Marie C; Crino, Lucio; Lena, Herve; Popat, Sanjay; Ahn, Jin Seok; Dansin, Eric; Golding, Sophie; Bordogna, Walter; Balas, Bogdana; Morcos, Peter N; Zeaiter, Ali; Shaw, Alice T